Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CHH NYSE:KSS NASDAQ:TGTX NASDAQ:UPST On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHHChoice Hotels International$116.66-0.4%$126.18$115.82▼$157.86$5.42B0.9375,480 shs271,871 shsKSSKohl's$16.55+0.8%$12.13$6.04▼$21.39$1.84B1.748.96 million shs6.49 million shsTGTXTG Therapeutics$32.21+1.0%$32.81$21.11▼$46.48$5.06B1.882.26 million shs2.23 million shsUPSTUpstart$66.90+1.6%$72.91$31.40▼$96.43$6.34B2.376.38 million shs5.81 million shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHHChoice Hotels International-0.41%-2.47%-6.57%-9.25%-7.30%KSSKohl's+0.86%+9.50%+41.33%+89.52%-19.61%TGTXTG Therapeutics+1.00%+9.82%+16.28%-19.60%+45.88%UPSTUpstart+1.56%-8.71%-1.15%+23.14%+84.15%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHHChoice Hotels International$116.66-0.4%$126.18$115.82▼$157.86$5.42B0.9375,480 shs271,871 shsKSSKohl's$16.55+0.8%$12.13$6.04▼$21.39$1.84B1.748.96 million shs6.49 million shsTGTXTG Therapeutics$32.21+1.0%$32.81$21.11▼$46.48$5.06B1.882.26 million shs2.23 million shsUPSTUpstart$66.90+1.6%$72.91$31.40▼$96.43$6.34B2.376.38 million shs5.81 million shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHHChoice Hotels International-0.41%-2.47%-6.57%-9.25%-7.30%KSSKohl's+0.86%+9.50%+41.33%+89.52%-19.61%TGTXTG Therapeutics+1.00%+9.82%+16.28%-19.60%+45.88%UPSTUpstart+1.56%-8.71%-1.15%+23.14%+84.15%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCHHChoice Hotels International 1.92Reduce$133.3814.34% UpsideKSSKohl's 1.69Reduce$12.46-24.66% DownsideTGTXTG Therapeutics 2.75Moderate Buy$46.2543.59% UpsideUPSTUpstart 2.36Hold$78.5417.40% UpsideCurrent Analyst Ratings BreakdownLatest CHH, TGTX, KSS, and UPST Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/28/2025KSSKohl'sCowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold8/28/2025KSSKohl'sCitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$8.00 ➝ $16.008/28/2025KSSKohl'sBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetUnderweight$5.00 ➝ $8.008/28/2025KSSKohl'sJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetUnderweight$10.00 ➝ $11.008/28/2025KSSKohl'sThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetSell$7.00 ➝ $11.008/28/2025KSSKohl'sRobert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$9.00 ➝ $15.008/28/2025KSSKohl'sUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetSell$4.00 ➝ $4.508/28/2025KSSKohl'sEvercore ISISubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetIn-Line$8.00 ➝ $13.008/27/2025KSSKohl'sGordon HaskettSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Accumulate8/27/2025KSSKohl'sTelsey Advisory GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetMarket Perform$9.00 ➝ $16.008/22/2025CHHChoice Hotels InternationalRobert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$144.00 ➝ $136.00(Data available from 9/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCHHChoice Hotels International$1.58B3.41$9.17 per share12.72($0.97) per share-120.27KSSKohl's$16.22B0.11$8.23 per share2.01$35.05 per share0.47TGTXTG Therapeutics$329M15.53$0.12 per share265.83$1.43 per share22.52UPSTUpstart$636.53M10.11N/AN/A$6.94 per share9.64Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCHHChoice Hotels International$299.67M$6.5017.9515.742.2119.52%-575.73%12.92%11/3/2025 (Estimated)KSSKohl's$109M$1.858.9413.56N/A1.31%4.62%1.27%11/25/2025 (Estimated)TGTXTG Therapeutics$23.38M$0.3787.0532.21N/A13.31%26.05%9.58%11/3/2025 (Estimated)UPSTUpstart-$128.58M-$0.08N/A71.94N/A-0.75%-5.95%-1.75%11/6/2025 (Estimated)Latest CHH, TGTX, KSS, and UPST EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/27/2025Q2 2026KSSKohl's$0.33$0.56+$0.23$1.35$3.37 billion$3.35 billion8/6/2025Q2 2025CHHChoice Hotels International$1.90$1.92+$0.02$1.75$430.13 million$426.44 million8/5/2025Q2 2025UPSTUpstart$0.27$0.36+$0.09$0.05$225.35 million$257.29 million8/4/2025Q2 2025TGTXTG Therapeutics$0.32$0.17-$0.15$0.17$147.76 million$141.15 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCHHChoice Hotels International$1.150.99%N/A17.69%N/AKSSKohl's$0.503.02%N/A27.03%N/ATGTXTG TherapeuticsN/AN/AN/AN/AN/AUPSTUpstartN/AN/AN/AN/AN/ALatest CHH, TGTX, KSS, and UPST DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/12/2025KSSKohl'squarterly$0.12503.9%9/10/20259/10/20259/24/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCHHChoice Hotels InternationalN/A0.890.89KSSKohl's1.001.360.19TGTXTG Therapeutics0.893.862.96UPSTUpstartN/A0.430.43Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCHHChoice Hotels International65.57%KSSKohl's98.04%TGTXTG Therapeutics58.58%UPSTUpstart63.01%Insider OwnershipCompanyInsider OwnershipCHHChoice Hotels International23.78%KSSKohl's1.00%TGTXTG Therapeutics10.64%UPSTUpstart16.67%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCHHChoice Hotels International1,70046.27 million35.27 millionOptionableKSSKohl's87,000112.04 million110.92 millionOptionableTGTXTG Therapeutics290158.67 million141.78 millionOptionableUPSTUpstart1,19396.22 million80.18 millionOptionableCHH, TGTX, KSS, and UPST HeadlinesRecent News About These CompaniesUpstart May Be A Future Victim Of AI - Downgrade To SellSeptember 6 at 3:26 AM | seekingalpha.comKBRA Assigns Preliminary Ratings to Upstart Securitization Trust 2025-3September 5 at 1:52 PM | businesswire.comUpstart's AI Underwriting Edge: Can It Keep Driving Loan Growth?September 5 at 12:06 PM | zacks.comIs UPST Stock a Buy, Hold, or Sell After Its 43.7% Three-Month Rally?September 2, 2025 | zacks.comInvestors Heavily Search Upstart Holdings, Inc. (UPST): Here is What You Need to KnowAugust 28, 2025 | zacks.comUpstart's Business Grew 154% Year Over Year, So Why Is the Stock Down?August 23, 2025 | fool.com3 Brilliant Fintech Stocks to Buy Now and Hold for the Long TermAugust 23, 2025 | fool.comWhy Upstart Rallied TodayAugust 22, 2025 | fool.comMy 5 Favorite Stocks to Buy Right NowAugust 22, 2025 | fool.comWhat Upstart's Earnings Say About the Health of Its BusinessAugust 21, 2025 | fool.com4 Fintech Growth Stocks to Buy With $260 and Hold ForeverAugust 19, 2025 | fool.comUpstart: GAAP Inflection PointAugust 18, 2025 | seekingalpha.comUpstart Stock Dropped After Earnings -- Could It Be a Screaming Bargain Right Now?August 17, 2025 | fool.comBetter Fintech Stock: Upstart vs. SoFi TechnologiesAugust 17, 2025 | fool.comThis Under-the-Radar AI Stock Could Double Your Money by 2028August 16, 2025 | fool.com3 Growth Stocks That Could Be Worth $1 Million in 5 YearsAugust 16, 2025 | fool.comHere is What to Know Beyond Why Upstart Holdings, Inc. (UPST) is a Trending StockAugust 14, 2025 | zacks.com1 Smart Growth Stock to Buy With Under $100 in AugustAugust 14, 2025 | fool.comUpstart Announces Upsize and Pricing of Offering of $600,000,000 of 0% Convertible Senior Notes Due 2032August 11, 2025 | businesswire.comWhy Is Upstart Stock Trading Lower On Monday?August 11, 2025 | benzinga.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 20253 Companies That Will Profit From Trump's Semiconductor TariffsBy Jordan Chussler | August 14, 20253 Robotics Stocks at the Heart of the Robotics RevolutionBy Chris Markoch | August 21, 2025Upstart Stock Could Pop on a Short Squeeze SoonBy Gabriel Osorio-Mazilli | August 20, 2025Kohl’s Stock Rebound Faces a Showdown With Short SellersBy Thomas Hughes | September 2, 2025CHH, TGTX, KSS, and UPST Company DescriptionsChoice Hotels International NYSE:CHH$116.66 -0.46 (-0.39%) Closing price 09/5/2025 03:59 PM EasternExtended Trading$116.80 +0.13 (+0.11%) As of 09/5/2025 04:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Choice Hotels International, Inc., together with its subsidiaries, operates as a hotel franchisor in the United States and internationally. It operates through Hotel Franchising & Management and Corporate & Other segments. The company franchises lodging properties under the brand names of Comfort Inn, Comfort Suites, Quality, Clarion, Clarion Pointe, Sleep Inn, Ascend Hotel Collection, Econo Lodge, Rodeway Inn, MainStay Suites, Suburban Studios, WoodSpring Suites, Everhome Suites, Cambria Hotels, Radisson Blu, Radisson RED, Radisson, Park Plaza, Country Inn & Suites by Radisson, Radisson Inn & Suites, Park Inn by Radisson, Radisson Individuals, and Radisson Collection. Choice Hotels International, Inc. was founded in 1939 and is headquartered in North Bethesda, Maryland.Kohl's NYSE:KSS$16.55 +0.13 (+0.76%) Closing price 09/5/2025 03:59 PM EasternExtended Trading$16.56 +0.01 (+0.09%) As of 09/5/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Kohl's Corporation operates as an omnichannel retailer in the United States. It offers branded apparel, footwear, accessories, beauty, and home products through its stores and website. The company provides its products primarily under the brand names of Croft & Barrow, Jumping Beans, SO, Sonoma Goods for Life, and Tek Gear, as well as Food Network, LC Lauren Conrad, Nine West, and Simply Vera Vera Wang. Kohl's Corporation was founded in 1988 and is headquartered in Menomonee Falls, Wisconsin.TG Therapeutics NASDAQ:TGTX$32.21 +0.32 (+1.00%) Closing price 09/5/2025 04:00 PM EasternExtended Trading$32.21 0.00 (0.00%) As of 09/5/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. It provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's development pipeline comprises Umbralisib, an oral inhibitor of PI3K-delta inhibitor for the treatment of adult patients with relapsed or refractory marginal zone lymphoma and follicular lymphoma; TG-1701 is an orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. Its research pipeline includes various investigational medicines. The company has license agreements with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; Rhizen Pharmaceuticals, S A. for the development and commercialization of umbralisib; Jiangsu Hengrui Medicine Co.; and Novimmune SA, as well as collaboration agreement with Checkpoint Therapeutics, Inc. for the development and commercialization of anti-PD-L1 and anti-GITR antibody research programs in the field of hematological malignancies. TG Therapeutics, Inc. was incorporated in 1993 and is based in Morrisville, North Carolina.Upstart NASDAQ:UPST$66.90 +1.03 (+1.56%) Closing price 09/5/2025 04:00 PM EasternExtended Trading$66.58 -0.33 (-0.49%) As of 09/5/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Upstart Holdings, Inc., together with its subsidiaries, operates a cloud-based artificial intelligence (AI) lending platform in the United States. Its platform includes personal loans, automotive retail and refinance loans, home equity lines of credit, and small dollar loans that connects consumer demand for loans to its to bank and credit unions. Upstart Holdings, Inc. was founded in 2012 and is headquartered in San Mateo, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/01 - 09/05 Lululemon Share Price Has Plenty of Room Left to Fall Why DocuSign Could Be a SaaS Value Play After Q2 Earnings Why Hedge Fund Elliott Bet $4B on Pepsi and Sees Over 50% Upside Palantir Insider Selling: Risk Signal or Normal Activity? Advanced Micro Devices' 2026 Forecasts Are Way Too Low Salesforce Stumbles, But Investors Eye a Major Comeback Buy the Dip? GitLab’s Bullish Case Outweighs the Bears Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
